Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.39567 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.40951 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.39967 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.5863 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.39529 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.32824 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.40165 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.39339 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.39086 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.59073 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.46504 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.39861 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.40337 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.39927 | 71 |